tolonium chloride


Also found in: Wikipedia.

to·lo·ni·um chlor·ide

(tō-lō'nē-ŭm klōr'īd),
The medicinal grade of toluidine blue O, used as an antiheparin compound.

tolonium chloride

see toluidine blue.
Mentioned in ?
References in periodicals archive ?
5 percent tolonium chloride solution, one bottle of 6.
OraBlu Oral Lesion Marking System
The Tblue630 marking system employs Zila Tolonium Chloride (ZTC(TM)), the only patented pharmaceutical-grade form of toluidine blue in an FDA-cleared device.
Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX
We are also very excited about the FDA's recent clearance to market our Zila(R) Tolonium Chloride marking product and we believe that this clearance will be beneficial to our efforts to build the market for ViziLite.
ZILA FISCAL 2005 2ND QTR NET REVENUES DECREASE 2%
Zila already holds several patents and has additional patent applications pending for the use of a specific dye, toluidine blue 0, or tolonium chloride, for the detection of oral cancer.
Zila issued additional patent related to the OraTest oral cancer detection product
The kit contains Zila's patented, pharmaceutical grade tolonium chloride rinse product.
Zila Receives Indefinite OraTest Marketing Authorization in Seven European Countries
ViziLite Plus combines the oral screening technology of ViziLite, an advanced biophotonic light technology, with TBlue630, a marking system using Zila(R) Tolonium Chloride (ZTC(TM)), the only patented pharmaceutical-grade form of toluidine blue used in marking lesions identified during a ViziLite examination.
'See Your Dentist - It Can Save Your Life,' Says Zila Pharmaceuticals, Inc., Promoting Oral, Head and Neck Cancer Awareness Week, April 17-22
This new reporting group consists of the OraTest product, expenses related to clinical trials for OraTest, and the Tolonium Chloride technology.
ZILA REPORTS 20.7 PERCENT INCREASE IN REVENUE
The subsidiary will operate as a comprehensive research, development and licensing business, specializing in pre-cancer/cancer detection through its patented Zila(R) Tolonium Chloride technology.
Zila Strengthens Biotechnology Business; Reports on Sufficient OraTest Funding, Adds Experts & Expands Objectives
During the third quarter of fiscal 2002, the company invested $1,018,000 in the OraTest(R)/Zila(R) Tolonium Chloride program, which encompasses the OraTest oral cancer detection product Phase III clinical trial, other OraTest research, and the broad Zila Tolonium Chloride research, development and manufacturing effort.
ZILA REPORTS HIGHER NET REVENUES FOR 3RD QTR FISCAL '02
Zila has three business units: Zila Pharmaceuticals, marketer of Zilactin(R) oral healthcare products, Peridex(R) prescription mouthrinse and ViziLite(R) oral examination kits, and manufacturer of patented swabs at Innovative Swab Technologies; Zila Nutraceuticals (Inter-Cal Nutraceuticals), manufacturer of patented Ester-C(R) branded products and Palmettx(R) Saw Palmetto; and, Zila BioTechnology, developer of OraTest(R) oral cancer detection products and Zila(R) Tolonium Chloride technologies for cancer and pre-cancer detection and treatment.
Zilactin(R), Zilactin(R)-L in a Cold Relief Management Coupon Promotion With Zicam(R) Cold Remedy
Zila President Joseph Hines said, "The restructured arrangement and the resulting completion of the transaction will allow management to concentrate on the growth of Zila's core business and on clinical work associated with its Zila(R) Tolonium Chloride and OraTest(R) products.
Zila and PracticeWares Agree to Restructure Transaction
While the OraTest product, as presently constituted, features the active ingredient Zila(R) Tolonium Chloride, this patent covers, but is not limited to using that particular staining dye.
Zila to be Issued Additional U.S. Patent for OraTest(R) Diagnostic Kit

Medical browser ?
Full browser ?